Repligen Corp. (NASDAQ: RGEN) has experienced a decline in its stock price by -1.92 compared to its previous closing price of 160.98. However, the company has seen a fall of -10.33% in its stock price over the last five trading days. GlobeNewsWire reported 2024-04-17 that Webcast and Conference Call to Be Held Wednesday, May 1, 2024, at 8:30 a.m. ET Webcast and Conference Call to Be Held Wednesday, May 1, 2024, at 8:30 a.m. ET
Is It Worth Investing in Repligen Corp. (NASDAQ: RGEN) Right Now?
The price-to-earnings ratio for Repligen Corp. (NASDAQ: RGEN) is above average at 219.07x. The 36-month beta value for RGEN is also noteworthy at 1.04. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 4 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
The public float for RGEN is 51.97M, and at present, short sellers hold a 9.18% of that float. The average trading volume of RGEN on April 18, 2024 was 538.66K shares.
RGEN’s Market Performance
The stock of Repligen Corp. (RGEN) has seen a -10.33% decrease in the past week, with a -20.54% drop in the past month, and a -9.37% fall in the past quarter. The volatility ratio for the week is 3.65%, and the volatility levels for the past 30 days are at 3.01% for RGEN. The simple moving average for the past 20 days is -11.99% for RGEN’s stock, with a -7.07% simple moving average for the past 200 days.
Analysts’ Opinion of RGEN
Wells Fargo, on the other hand, stated in their research note that they expect to see RGEN reach a price target of $185. The rating they have provided for RGEN stocks is “Overweight” according to the report published on July 20th, 2023.
JP Morgan gave a rating of “Overweight” to RGEN, setting the target price at $220 in the report published on July 05th of the previous year.
RGEN Trading at -17.00% from the 50-Day Moving Average
After a stumble in the market that brought RGEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -25.22% of loss for the given period.
Volatility was left at 3.01%, however, over the last 30 days, the volatility rate increased by 3.65%, as shares sank -19.66% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -21.18% lower at present.
During the last 5 trading sessions, RGEN fell by -10.24%, which changed the moving average for the period of 200-days by +11.28% in comparison to the 20-day moving average, which settled at $177.46. In addition, Repligen Corp. saw -12.19% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at RGEN starting from KURIYEL RALF, who sale 3,517 shares at the price of $193.73 back on Mar 11 ’24. After this action, KURIYEL RALF now owns 24,260 shares of Repligen Corp., valued at $681,348 using the latest closing price.
Hunt Anthony, the Chief Executive Officer of Repligen Corp., sale 16,707 shares at $197.44 during a trade that took place back on Mar 08 ’24, which means that Hunt Anthony is holding 185,249 shares at $3,298,632 based on the most recent closing price.
Stock Fundamentals for RGEN
Current profitability levels for the company are sitting at:
- 0.09 for the present operating margin
- 0.45 for the gross margin
The net margin for Repligen Corp. stands at 0.07. The total capital return value is set at 0.02. Equity return is now at value 2.14, with 1.55 for asset returns.
Based on Repligen Corp. (RGEN), the company’s capital structure generated 0.23 points at debt to capital in total, while cash flow to debt ratio is standing at 0.19. The debt to equity ratio resting at 0.3. The interest coverage ratio of the stock is -27.97.
Currently, EBITDA for the company is 131.39 million with net debt to EBITDA at -0.9. When we switch over and look at the enterprise to sales, we see a ratio of 13.78. The receivables turnover for the company is 5.14for trailing twelve months and the total asset turnover is 0.23. The liquidity ratio also appears to be rather interesting for investors as it stands at 7.02.
Conclusion
In summary, Repligen Corp. (RGEN) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
